TGD001 is a groundbreaking thrombolytic designed to break down clots of all sizes and compositions – from large clots which cause AIS, down to ‘micro-clots’ which cause conditions such as the rare, ...
Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic ® urokinase, a biologic thrombolytic drug used to treat ...